Key Highlights
- New Mountain Capital is backing SmarterDx at a billion-dollar valuation, according to a source familiar with the transaction.
- SmarterDx raises strategic growth capitalfrom New Mountain Capital, supporting its clinical AI platform.
- Over 40 health systems and 180 hospitalsuse SmarterDx’s platform to improve revenue integrity and care quality.
- SmarterDx’s solutions—SmarterPrebill™ and SmarterDenials™—deliver a 5:1 ROI from Day One.
- Recognized by Modern Healthcareas a 2024 “Best in Business” in the Newcomer – Startups category.
Source: Business Wire
Notable Quotes
- “This strategic investment marks a pivotal moment in our journey to scale our AI platform and build new products that further helps capture hospitals’ differential – whether that’s in earned revenue, care quality, or operational efficiency.” — Michael Gao, Co-Founder and CEO at SmarterDx
- “Our north star is to help hospitals, and this will accelerate our ability to build AI solutions that drive real outcomes.” — Joshua Geleris, Co-Founder and Head of Product and Data Science at SmarterDx
- “We have been deeply impressed by the SmarterDx platform and the physician-led team that Dr. Gao and Dr. Geleris have built.” — Matt Holt, Managing Director and President, Private Equity at New Mountain Capital
Why This Matters
The strategic investment from New Mountain Capital marks a significant milestone for SmarterDx as it accelerates innovation in clinical AI. Backed at a billion-dollar valuation, this move highlights growing confidence in AI-driven revenue cycle solutions. By enhancing hospitals’ ability to analyze patient records and secure accurate reimbursements, SmarterDx supports both financial performance and patient care quality across health systems. This partnership underscores a broader industry trend of integrating clinical and administrative technologies to drive outcomes in healthcare.
